Immunogenicity after two and three doses of mRNA vaccine in patients with cancer treated with exclusive radiotherapy

CONCLUSION: In patients treated with exclusive RT, even during the Omicron breakthrough, robust humoral response and clinical protection from severe SARS-CoV-2 disease were achievable with three doses of mRNA vaccine.PMID:37392566 | DOI:10.1016/j.intimp.2023.110460

Source: International Immunopharmacology - July 1, 2023 Category: Allergy & Immunology Authors: Silvia Scoccianti Camilla Delli Paoli Maria Infantino Lisa Paoletti Saverio Caini Fiammetta Meacci Serenella Russo Marco Esposito Simona Fondelli Barbara Grilli Leonulli Valentina Grossi Raffaella Barca Paolo Alpi Federica Furlan Marco Perna Maria Simona Source Type: research